Details for New Drug Application (NDA): 019775
✉ Email this page to a colleague
The generic ingredient in MINIPRESS XL is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
Summary for 019775
Tradename: | MINIPRESS XL |
Applicant: | Pfizer |
Ingredient: | prazosin hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019775
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 2.5MG | ||||
Approval Date: | Jan 29, 1992 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MG | ||||
Approval Date: | Jan 29, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 019775
Complete Access Available with Subscription